| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0026 | 1 |